Microneedling Market Summary
According to Market Research Future analysis, the Microneedling Market Size was valued at USD 0.5626 Billion in 2024. The market is projected to grow from USD 0.6206 Billion in 2025 to USD 1.656 Billion by 2035, registering a CAGR of 10.3% during the forecast 2025–2035. North America led the market with over 35.55% share, generating around USD 0.2 Billion in revenue.
Growing preference for minimally invasive aesthetic procedures, rising adoption of advanced microneedling devices, and increasing demand for effective skin rejuvenation solutions are driving strong market expansion globally, supported by enhanced consumer awareness and improved dermatology service accessibility.
WHO reports that over 1.5 billion people experience skin conditions annually, increasing demand for dermatological treatments. CDC highlights that minimally invasive cosmetic procedures grew by over 22% in recent years, reflecting rising consumer interest in safe, non-surgical aesthetic solutions.
Key Market Trends & Highlights
The Microneedling Market is poised for substantial growth driven by technological advancements and increasing consumer awareness.
- North America led with 35.55% of global microneedling revenue in 2024.
- Europe reached USD 0.17 billion value in 2024, holding a 30% regional market share.
- RF microneedling dominated 2024 with 48% share, driven by strong demand for advanced skin-tightening and rejuvenation treatments.
- Metal needles accounted for 57% share due to durability and precision, reinforcing their dominance across dermatology procedures in 2024.
Market Size & Forecast
| 2024 Market Size | 0.5626 (USD Billion) |
| 2035 Market Size | 1.656 (USD Billion) |
| CAGR (2025 - 2035) | 10.31% |
Major Players
Companies such as Revance Therapeutics (US), Merz Pharmaceuticals (DE), Cynosure (US), Hyaluronic Acid (US), Dermaroller (DE), SkinPen (US), Bellus Medical (US), Aesthetics Biomedical (US), Medytox (KR) are some of the major participants in the global market.